Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.49
(
-0.41%
)
US TECH 100
26,048.00
(
-0.60%
)
Dow Jones
49,315.35
(
-0.35%
)
Brent Oil
100.81
(
4.22%
)
Bitcoin
77,877.02
(
-0.46%
)
News Focus
News Focus
Post# of 257440
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122884
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 97461

Friday, 09/24/2010 1:35:24 PM

Friday, September 24, 2010 1:35:24 PM

Post# of 257440
EU’s CHMP approves NVS’ Tasigna for first-line CML:

http://www.novartis.com/newsroom/media-releases/en/2010/1446754.shtml

FDA approval of Tasigna for first-line CML occurred in Jun 2010 (#msg-51437844). BMY’s Spycel has a 10/28/10 PDUFA date for the same indication.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today